Outcomes of active surveillance for Japanese patients with prostate cancer ( PRIAS ‐ JAPAN )

Documenti analoghi

• Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance ( PRIAS) ‐ JAPAN study
  di: Takuma Kato, et al.
  Pubblicazione: (2026)
• How widespread is active surveillance of early‐stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early‐stage prostate cancer in Japan
  di: Takuma Kato, et al.
  Pubblicazione: (2024)
• Active Surveillance in Prostate Cancer With Intermediate‐Risk Features: The PRIAS‐JAPAN Study
  di: Leandro Blas, et al.
  Pubblicazione: (2025)
• A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection
  di: Tomoko Honda, et al.
  Pubblicazione: (2025)
• Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study
  di: Yoichiro Tohi, et al.
  Pubblicazione: (2024)